Location History:
- Kyunggi-do, KR (2002)
- Sungnam-si, KR (2006)
Company Filing History:
Years Active: 2002-2006
Title: Seung Wook Lim: Innovator in Biopharmaceuticals
Introduction
Seung Wook Lim is a prominent inventor based in Sungnam-si, South Korea. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of novel therapeutic agents. With a total of 2 patents, his work focuses on enhancing medical treatments through innovative approaches.
Latest Patents
One of his latest patents is titled "Human thrombopoietin comprising glycosylation sited at residues 157 and 164." This invention relates to novel human thrombopoietin (hTPO) derivatives and the process of their preparation. The innovation involves introducing sugar chains into native hTPO by substituting amino acids at specific positions, resulting in hTPO derivatives that enhance platelet production in vivo. These derivatives may be beneficial for treating thrombocytopenia associated with anticancer therapy or bone marrow transplantation.
Another significant patent is for a "Topical composition containing human epidermal growth factor." This invention focuses on a topical formulation that includes human epidermal growth factor (hEGF) and a polyoxyethylene-polyoxypropylene copolymer. The formulation is designed to improve the wound healing ability of hEGF, showcasing Lim's commitment to advancing therapeutic options.
Career Highlights
Seung Wook Lim is currently associated with Daewoong Pharmaceutical Co., Ltd., where he continues to innovate in the biopharmaceutical sector. His work has garnered attention for its potential impact on patient care and treatment outcomes.
Collaborations
Throughout his career, Lim has collaborated with notable colleagues, including Seung Yeob Lee and Jin Seok Kang. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Seung Wook Lim is a distinguished inventor whose work in biopharmaceuticals is paving the way for new treatment options. His innovative patents reflect a deep commitment to improving healthcare through scientific advancements.